Evidence map›Paper›PMID 32898758›Full record

ArticleSeminars in arthritis and rheumatism2020

Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.

Antonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, Susanna Proudman, Dinesh Khanna, Amber Young, Monique Hinchcliff, Virginia Steen, Jessica Gordon, Vivien Hsu and 6 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Seminars in arthritis and rheumatism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06155578 (Randomized Placebo-controlled Trial of the Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis.), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06155578 phase1 / phase2unknown statusnot on this mapstarted 2024, after this paper: background citation

Randomized Placebo-controlled Trial of the Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis.

TypeinterventionalSponsorPontificia Universidad Catolica de ChileRan2024 to 2024Enrolled20ConditionsSystemic Sclerosis, CalcinosisArmsTopical 25% sodium metabisulfite (SM) in pediatric cold cream, Placebo
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Calcinosis in dermatomyositis.Current opinion in rheumatology · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Calcinosis in dermatomyositis: Origins and possible therapeutic avenues.Best practice & research. Clinical rheumatology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 5 countries.

Antonia ValenzuelaPontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Murray BaronDivision of Rheumatology, Jewish General Hospital, McGill University, Canada.
Tatiana S Rodriguez-ReynaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Department of Immunology and Rheumatology, Mexico.
Susanna ProudmanRoyal Adelaide Hospital North Terrace, Rheumatology Unit and Discipline of Medicine, University of Adelaide, Australia.
Dinesh KhannaUniversity of Michigan Scleroderma Program, Department of internal medicine, Division of Rheumatology, USA.
Amber YoungUniversity of Michigan Scleroderma Program, Department of internal medicine, Division of Rheumatology, USA.
Monique HinchcliffYale University School of Medicine, Section of Rheumatology, Allergy and Clinical Immunology, USA.
Virginia SteenGeorgetown University, Division of Rheumatology, USA.
Jessica GordonHospital for Special Surgery, Department of Rheumatology, USA.
Vivien HsuRutgers-RWJ Medical School, Rheumatology Division, USA.
Flavia V CastelinoHarvard Medical School, Division of Rheumatology, USA.
Sara SchoenfeldHarvard Medical School, Division of Rheumatology, USA.
Shufeng LiStanford University School of Medicine, Department of Dermatology, USA.
Joy Y WuStanford University School of Medicine, Department of Medicine, Division of Endocrinology, USA.
David FiorentinoStanford University School of Medicine, Department of Dermatology, USA.
Lorinda ChungStanford University School of Medicine and Palo Alto VA Health Care System, Department of Immunology and Rheumatology and Dermatology (by courtesy), USA. Electronic address: shauwei@stanford.edu.
Stanford University · USHarvard University · USGeorgetown University · USHospital for Special Surgery · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXJewish General Hospital · CAPontificia Universidad Católica de Chile · CLRutgers, The State University of New Jersey · USScleroderma Foundation · USUniversity of Adelaide · AUUniversity of Michigan–Ann Arbor · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosisR01AR073270 · NIAMS · YALE UNIVERSITY · PI HINCHCLIFF, MONIQUE EVANGELINE · 2019 to 2023
$2.6M
Outcomes Research in Rheumatic DiseasesK24AR063120 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KHANNA, DINESH · 2012 to 2022
$1.6M
NCATS NIH HHS UL1 TR001863NIAMS NIH HHS K24 AR063120NIAMS NIH HHS R01 AR073270
6 · The paper itself

Abstract

objectiveCalcinosis is a debilitating complication of systemic sclerosis (SSc) with no effective treatments. We sought to identify clinical correlations and to characterize complications and disability associated with calcinosis in a multi-center, international cohort of SSc patients.

methodsWe established a cohort of 568 consecutive SSc patients who fulfill 2013 revised ACR/EULAR criteria at 10 centers within North America, Australia, and Mexico. Calcinosis was defined as subcutaneous calcium deposition by imaging and/or physical examination, or a clear history of extruded calcium. All patients completed the Scleroderma Health Assessment Questionnaire Disability Index and Cochin Hand Functional Scale.

results215 (38%) patients had calcinosis. In multivariable analysis, disease duration (OR=1.24, p = 0.029), digital ischemia (OR=1.8, p = 0.002) and Acro-osteolysis (OR=2.97, p = 0.008) were significantly associated with calcinosis. In the subset of patients with bone densitometry (n = 68), patients with calcinosis had significantly lower median T-scores than patients without (-2.2 vs. -1.7, p = 0.004). The most common location of calcinosis lesions was the hands (70%), particularly the thumbs (19%) with decreasing frequency moving to the fifth fingers (8%). The most common complications were tenderness (29% of patients) and spontaneous extrusion of calcinosis through the skin (20%), while infection was rare (2%). Disability and hand function were worse in patients with calcinosis, particularly if locations in addition to the fingers/thumbs were involved.

conclusionsWe confirmed a strong association between calcinosis and digital ischemia. Calcinosis in SSc patients most commonly affects the hands and is associated with a high burden of disability and hand dysfunction.

Indexed as

Acro-OsteolysisCalcinosisScleroderma, SystemicHandHumansIschemiaAcro-osteolysisCalcinosisDigital ischemiaDisabilityOsteoporosisScleroderma

Identifiers

PMID32898758
PMCPMC8205269
OpenAlexW3036639391

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.